Nicholas Restifo, based in Bethesda, Maryland, United States, is currently a Chief Scientist, Head of R&D at Marble Therapeutics, bringing experience from previous roles at The National Institutes of Health, RestifoPartners, LLC and Lyell Immunopharma. Nicholas Restifo holds a 1989 - 2019 Principal Investigator in Cancer Immunotherapy @ National Cancer Institute (NCI), Bethesda. With a robust skill set that includes Molecular Biology, Cancer Research, Clinical Trials, Biochemistry, Biotechnology and more, Nicholas Restifo contributes valuable insights to the industry. Nicholas Restifo has 2 emails and 1 mobile phone number on RocketReach.